"Receptors, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.
| Descriptor ID |
D011971
|
| MeSH Number(s) |
D12.776.543.750.705
|
| Concept/Terms |
Receptors, Immunologic- Receptors, Immunologic
- Immunologic Receptors
- Immunological Receptors
- Receptors, Immunological
- Immunologic Receptor
- Receptor, Immunologic
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Immunologic".
- Receptors, Immunologic
- Costimulatory and Inhibitory T-Cell Receptors
- Immunophilins
- Integrins
- Leukocyte Immunoglobulin-like Receptor B1
- Lipopolysaccharide Receptors
- Platelet Membrane Glycoproteins
- Receptors, Antigen
- Receptors, Complement
- Receptors, Cytokine
- Receptors, Fc
- Receptors, Formyl Peptide
- Receptors, Laminin
- Receptors, Lymphocyte Homing
- Receptors, Mitogen
- Receptors, Natural Killer Cell
- Receptors, Pattern Recognition
- Receptors, Scavenger
- Signaling Lymphocytic Activation Molecule Family
- Triggering Receptor Expressed on Myeloid Cells-1
This graph shows the total number of publications written about "Receptors, Immunologic" by people in this website by year, and whether "Receptors, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 1 | 4 |
| 2013 | 1 | 3 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 3 | 3 | 6 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Immunologic" by people in Profiles.
-
Protective role for kidney TREM2high macrophages in obesity- and diabetes-induced kidney injury. Cell Rep. 2024 Jun 25; 43(6):114253.
-
SHIP inhibition mediates select TREM2-induced microglial functions. Mol Immunol. 2024 Jun; 170:35-45.
-
Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Biomolecules. 2021 07 27; 11(8).
-
TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis. J Autoimmun. 2020 07; 111:102441.
-
The relationship between TIGIT+ regulatory T cells and autoimmune disease. Int Immunopharmacol. 2020 Jun; 83:106378.
-
Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report. Medicine (Baltimore). 2020 Feb; 99(8):e18889.
-
The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis. Mol Genet Genomics. 2018 Jun; 293(3):601-613.
-
Check point inhibitors as therapies for infectious diseases. Curr Opin Immunol. 2017 Oct; 48:61-67.
-
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. J Bone Miner Res. 2017 Nov; 32(11):2207-2218.
-
Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017 06 20; 46(6):1018-1029.e7.